USD
GBP 
CNY 
EUR 
INR 
JPY 
MYR 
ZAR 
KRW 
THB 
Future Options for End Users
17-Mar-2015
Global
Market Research
P85B-01-00-00-00
LS00146-GL-MR_16987
The global diabetes drug delivery market is mainly divided into injectable drug delivery and oral drug delivery systems. The trend will continue in 2015, as four major products: Afrezza (inhalable drug delivery product of MannKind distributed by Sanofi), Tanzeum (injectable pen), Xigduo XR (oral), and Xultophy (injectable pen) enter the US and European diabetes markets. Depending on end-user acceptability of inhalable diabetes drugs, the global diabetes market can expect an increase in future investments. With the exception of one approved inhalable drug delivery system, there are no other inhalable products in the diabetes clinical pipeline at present.
Key Findings
Key Findings—Options in the Global Diabetes Drug Delivery Market
Unmet Needs in the Diabetes Drug Delivery Market
Pumps or Pens—Future Investment Opportunities for Type 1 Diabetes
Scope and Segmentation
Key Questions This Study Will Answer
Market Engineering Measurements
CEO’s Perspective
Key Companies to Watch
3 Key Predictions
Market Background
Market Segmentation
Market Segmentation (continued)
Global Diabetes Drug Delivery Market—Type of Delivery Usage by Region
New Market Opportunities
New Market Opportunities (continued)
Pipeline of Diabetes Drug Delivery Systems
Attractiveness in Diabetes Drug Delivery Market
Market Drivers
Market Restraints
Market Engineering Measurements
Forecast Assumptions
Revenue Forecast
Revenue Forecast by Type of Diabetes Drug Delivery
Revenue Forecast Discussion
Top Competitors
Market Engineering Measurements
Injectable Diabetes Drug Delivery Market—Revenue Forecast
Revenue Forecast Discussion
Injectable Diabetes Drug Delivery Market—Competitive Assessment
Promising Injectable—Once-a-week Diabetes Drug
Market Engineering Measurements
Oral Diabetes (Non-insulin) Drug Delivery Market—Revenue Forecast
Revenue Forecast Discussion
Oral Diabetes Drug Delivery Market—Competitive Assessment
Market Engineering Measurements
Inhalable Diabetes Drug Delivery Market—Revenue Forecast
Inhalable Diabetes Drug Delivery Market—Competitive Assessment
Inhalable Drug Delivery System and Injectable Drug Delivery System
The United States—New Technologies in Diabetes Drug Delivery
The United States—Trends in Diabetes Drug Delivery
Europe—New Technologies in Diabetes Drug Delivery
Europe—Trends in Diabetes Drug Delivery
APAC (India)—New Technologies in Diabetes Drug Delivery
APAC (India)—Trends in Diabetes Drug Delivery Market
Becton Dickinson and Company
Gerresheimer Bünde
Owen Mumford Ltd
Zosano Pharma Corporation
ViaCyte, Inc.
Echo Therapeutics
Conclusion
Frost & Sullivan Awards
Legal Disclaimer
Market Engineering Methodology
Drivers Explained
Drivers Explained (continued)
Restraints Explained
Learn More—Next Steps
Speak directly with our analytics experts for tailored recommendations.
Recent related Life Sciences research
13 Jan 2025 | Global | Market Outlook
Top 6 Growth Opportunities for the Digital Health Industry, 2025
Driven by digital advancements, the healthcare industry is transforming rapidly. Current trends and challenges create constant change, and industry stakeholders must adapt to remain attractive, competitive, and unique as robust organizations. Each year, competitors must gain a fresh, comprehensive v...
17 Dec 2024 | Global | Market Research
Cybersecurity in Healthcare, United States, 2024
Healthcare is the industry most affected by cyberattacks, which have targets like hospitals, healthcare organizations, patient databases, and connected devices. These attacks not only destabilize healthcare systems but also threaten care delivery and patient safety. The global healthcare infrastruct...
12 Dec 2024 | Global | Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and trans...
05 Dec 2024 | Global | Frost Radar
Frost Radar™: Enterprise Conversational AI in Healthcare, 2024
This Frost Radar™ benchmarks the companies and their solutions that allow healthcare payers and providers to create next-generation virtual assistants. Conversational AI is primarily used to streamline patient and provider processes and interactions across the care continuum—the pre-care, at-care, a...
27 Nov 2024 | Global | Market Research
Generative AI in Payer and Provider IT Transformation, Global, 2024-2029
The healthcare payer and provider industry is gradually adopting generative artificial intelligence (Gen AI) solutions across its value chain. Almost all organizations have shown an intent to implement Gen AI-based solutions in their products or processes, with a few already embarking on this journe...
Purchase includes:
- Report download
- Growth Dialog™ with our experts
Growth Dialog™
A tailored session with you where we identify the:- Strategic Imperatives
- Growth Opportunities
- Best Practices
- Companies to Action
Impacting your company's future growth potential.
| Deliverable Type | Market Research |
|---|---|
| No Index | No |
| Podcast | No |
| Author | Siddharth Dutta |
| WIP Number | P85B-01-00-00-00 |
| Is Prebook | No |
Analysis of the Global Diabetes Drug Delivery Market
$4,950.00
Special Price $3,712.50 save 25 %